Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
334.85
0.00 (0.00%)
Oct 3, 2024, 8:31 AM EST - Market closed
Bio-Rad Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 9,119 | 9,399 | 12,460 | 22,439 | 17,345 | 11,075 | |
Market Cap Growth | -10.76% | -24.57% | -44.47% | 29.37% | 56.62% | 59.43% | |
Enterprise Value | 8,885 | 9,046 | 11,989 | 21,328 | 16,836 | 10,761 | |
Last Close Price | 326.74 | 320.65 | 404.66 | 722.91 | 574.15 | 369.60 | |
PE Ratio | - | - | - | 5.27 | 4.55 | 6.30 | |
PS Ratio | 3.60 | 3.52 | 4.45 | 7.68 | 6.81 | 4.79 | |
PB Ratio | 1.24 | 1.08 | 1.30 | 1.64 | 1.76 | 1.92 | |
P/TBV Ratio | 1.37 | 1.17 | 1.40 | 1.72 | 1.85 | 2.07 | |
P/FCF Ratio | 36.91 | 43.07 | 152.67 | 41.88 | 36.41 | 30.82 | |
P/OCF Ratio | 22.13 | 25.07 | 64.10 | 33.52 | 29.65 | 24.19 | |
EV/Sales Ratio | 3.44 | 3.39 | 4.28 | 7.30 | 6.61 | 4.66 | |
EV/EBITDA Ratio | 18.38 | 17.68 | 19.21 | 30.37 | 30.07 | 29.58 | |
EV/EBIT Ratio | 26.61 | 24.74 | 24.63 | 37.77 | 39.96 | 46.86 | |
EV/FCF Ratio | 35.96 | 41.45 | 146.89 | 39.81 | 35.34 | 29.95 | |
Debt / Equity Ratio | 0.19 | 0.16 | 0.14 | 0.02 | 0.02 | 0.11 | |
Debt / EBITDA Ratio | 2.52 | 2.44 | 2.04 | 0.30 | 0.37 | 1.58 | |
Debt / FCF Ratio | 5.62 | 6.44 | 17.01 | 0.42 | 0.47 | 1.81 | |
Asset Turnover | 0.23 | 0.21 | 0.18 | 0.19 | 0.24 | 0.34 | |
Inventory Turnover | 1.48 | 1.65 | 1.91 | 2.11 | 1.88 | 1.85 | |
Quick Ratio | 4.21 | 4.03 | 4.04 | 1.90 | 2.24 | 1.67 | |
Current Ratio | 6.14 | 5.83 | 5.55 | 2.92 | 3.39 | 2.41 | |
Return on Equity (ROE) | -9.79% | -6.94% | -31.14% | 36.11% | 48.79% | 35.98% | |
Return on Assets (ROA) | 1.85% | 1.77% | 1.94% | 2.29% | 2.51% | 2.11% | |
Return on Capital (ROIC) | 2.23% | 2.16% | 2.44% | 2.94% | 3.19% | 2.64% | |
Earnings Yield | -8.54% | -6.78% | -29.11% | 18.96% | 21.99% | 15.88% | |
FCF Yield | 2.71% | 2.32% | 0.66% | 2.39% | 2.75% | 3.24% | |
Buyback Yield / Dilution | 3.47% | 1.93% | 1.40% | -0.16% | 0.08% | 0.15% | |
Total Shareholder Return | 3.47% | 1.93% | 1.40% | -0.16% | 0.08% | 0.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.